It has been previously shown that increased CD90 expression is associated with worse overall and disease-free survival in other malignancies such as hepatocellular carcinoma, intrahepatic cholangiocarcinoma, gallbladder cancer, breast cancer, chondrosarcoma, gastric cancer [32,33]. This evidence concerns the gene THY1 and breast cancer.